120 Participants Needed

Mindfulness-Based Relapse Prevention for Alcohol Consumption

(WAVE Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of New Mexico
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to examine the effects of mindfulness based relapse prevention on self-regulation overtime and drinking in daily life through the use of wearable heart rate sensors during mindfulness groups and answering assessment questions 3 times per day during the course of treatment. The main questions that it aims to answer are:1. What changes in self-regulation as measured through heart rate variability are observed during a mindfulness intervention and how do those self-regulatory changes affect drinking after treatment?2. How do changes in heart rate variability affect drinking, craving, and negative affectivity in daily life?Participants will:1. Answer questions related to their mood and drinking behaviors.2. Wear their sensors during an 8-week treatment period with 1 group per week.3. Answer questions 3 times a day during the treatment period. 4.) Return their sensors via a pre-stamped package and answer questions about their mood and drinking behaviors 3- and 6-months after the mindfulness groups end.

Who Is on the Research Team?

MW

Matison W McCool, Phd

Principal Investigator

Center on Alcohol, Substance use, And Addictions - The University of New Mexico

Are You a Good Fit for This Trial?

This trial is for individuals struggling with alcoholism or excessive alcohol consumption. Participants will be required to wear heart rate sensors, attend weekly mindfulness groups for 8 weeks, and answer questions about their mood and drinking habits three times a day during treatment.

Inclusion Criteria

I can attend group meetings as scheduled.
Willing to wear a sensor for the 8-week intervention period and return the sensor after the immediate follow-up
Have a phone/tablet/computer with internet access
See 3 more

Exclusion Criteria

I am experiencing symptoms of psychosis or mania.
Have a substance use disorder requiring a higher level of care than outpatient treatment (e.g., severe alcohol use disorder requiring inpatient detoxification)
I have heart or lung conditions that could affect heart rate data.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in an 8-week mindfulness-based relapse prevention program, wearing HRV sensors and answering questions about mood and drinking behaviors 3 times a day.

8 weeks
8 group sessions (in-person or virtual)

Follow-up

Participants return sensors and answer questions about mood and drinking behaviors at 3- and 6-months post-treatment.

6 months
2 follow-up assessments (remote)

What Are the Treatments Tested in This Trial?

Interventions

  • Mindfulness based relapse prevention
Trial Overview The study tests if mindfulness-based relapse prevention can improve self-regulation as seen through changes in heart rate variability (HRV) and how these changes may affect drinking behavior, cravings, and negative emotions both during the intervention and up to six months after it ends.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: MBRPExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of New Mexico

Lead Sponsor

Trials
393
Recruited
3,526,000+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security